Guizhou Yibai Pharmaceutical Co. Ltd. A | Ownership
Companies that own Guizhou Yibai Pharmaceutical Co. Ltd. A
China Asset Management Co., Ltd.
17,648,035
2.23%
-3,017,596
0.1%
09/30/2017
China Universal Asset Management Co., Ltd.
10,500,078
1.33%
-23,724,586
0.1%
09/30/2017
China Investment Corp. (Investment Management)
9,176,200
1.15%
0
0.03%
09/30/2017
Goldstate Capital Fund Management Co., Ltd.
9,060,000
1.13%
9,060,000
0.75%
09/30/2017
Bosera Asset Management Co., Ltd.
8,499,968
1.07%
-1,955,826
0.08%
09/30/2017
Harvest Fund Management Co., Ltd.
7,314,980
0.92%
-8,200
0.06%
12/31/2017
China Southern Asset Management Co., Ltd.
2,835,137
0.36%
-169,800
0.03%
12/31/2017
Huashang Fund Management Co., Ltd.
2,616,787
0.33%
-1,200,000
0.12%
12/31/2017
Guotai Asset Management Co., Ltd.
1,828,737
0.23%
-1,213,162
0.03%
12/31/2017
Guotai Junan Allianz Fund Management Co., Ltd.
1,287,658
0.16%
-2,846,600
0.09%
12/31/2017
| Address |
No. 220-1 Baiyun Avenue
Guiyang Guizhou 550008
China
|
|
Employees
|
- |
| Website |
http://e.gzcci.com |
| Updated |
07/08/2019 |
| Guizhou Yibai Pharmaceutical Co., Ltd. engages in the manufacture and distribution of pharmaceutical products. Its business activities include the production and sale of capsules, small-volume injection, tablet, granules, bran paste agent, freeze-dried powder, oral solution; production and sale of medicine for respiratory disease; and cardiovascular disease prevention and treatment. The company also engages in the export of self-produced products and related technology; import of raw and auxiliary materials; machinery and equipment; spare parts and related technologies as required by company's production and research. |
